Analysts' Upgrades and Downgrades
Tuesday's Analysts' Upgrades, Downgrades
TheStreet.com Ratings Staff
05/13/08 - 09:26 AM EDT
Change in Ratings
Barr Pharma(BRL - Cramer's Take - Stockpickr) upgraded at Cowen from neutral to outperform. Risks are factored into the stock, and the company should soon enter a solid U.S. product cycle.
ICF(ICFI - Cramer's Take - Stockpickr) upgraded at UBS to buy rating from neutral. Price target and fiscal year 2008 EPS estimates hold at $22 and $1.47.
Sirius Satellite(SIRI - Cramer's Take - Stockpickr) upgraded at Merrill to neutral. Company showed solid subscriber growth in the first quarter, and negative sentiment toward the stock is likely passed its peak.
Stock Comments/EPS Changes
Fluor(FLR - Cramer's Take - Stockpickr) numbers raised at UBS. Price target rockets to $215 from $165 and fiscal year 2008 EPS jumps to $6.40 from $5.50. Reiterates buy rating.
Fluor price target raised at Goldman to $175 from $155 following better-than-expected first-quarter earnings and raised 2008 guidance. See positive outlook for endmarkets. Maintained neutral rating.
Moody's(MCO - Cramer's Take - Stockpickr) initiated at Jefferies with buy rating. Price target starts at $47 with 2008 EPS estimates set at $1.95.
McGraw-Hill(MHP - Cramer's Take - Stockpickr) initiated at Jefferies with buy rating. Price target starts at $49 with 2008 EPS estimates set at $2.80.
Research In Motion(RIMM - Cramer's Take - Stockpickr) target raised at Goldman to $148 from $145 based on increased confidence in BlackBerry ecosystem and ability to gain market share in smartphone market. Note additional 3G/WiFi enabled devices shipping in 2008 and extending product cycle.
Sprint Nextel(S - Cramer's Take - Stockpickr) numbers raised at UBS. Price target lifts to $10 from $7.25 and fiscal year 2009 EPS goes positive to 14 cents from loss of 18 cents. Reiterates neutral rating.
